Scorpion details early data on targeted breast cancer drug as it seeks to challenge Novartis, Roche
Read More
Archive for In The News
Scorpion raises $150M with sights on the next wave of targeted therapies
Read More
Scorpion snaps up $150M in series C funds to widen clinical plans for cancer pipeline
Read More
Scorpion Partners Two Assets With Pierre Fabre To Prioritize Investment In A Third
Read More
Scorpion scores $65M as it lines up a partner to take EGFR programs global
Read More
Scorpion snags $553M deal with Pierre Fabre for 2 preclinical lung cancer assets
Read More
Scorpion Therapeutics Accelerates Precision Oncology 2.0 for More Patient Populations
Read More
Fierce Biotech’s 2022 Fierce 15
Read More
Axel Hoos Wants to Take Small Molecules Further at Scorpion, Leaving Big Pharma in the Dust
Read More
Weixue Wang: This Assay Inventor Identifies Drug Candidates for Targets Once Thought to be Undruggable
Read More